Arrowstreet Capital
PDLI

Arrowstreet Capital’s PDL BioPharma, Inc. PDLI Stock Holding History

Arrowstreet Capital’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,293,289
Closed -$4.07M – 2647
2020
Q3 		$4.07M Buy
1,293,289
+524,208
+68% +$1.67M 0.01% 1239
2020
Q2 		$2.24M Buy
769,081
+752,481
+4,533% +$2.38M ﹤0.01% 1427
2020
Q1 		$47K Sell
16,600
-177,400
-91% -$572K ﹤0.01% 1824
2019
Q4 		$630K Sell
194,000
-204,950
-51% -$595K ﹤0.01% 1445
2019
Q3 		$862K Sell
398,950
-1,426,431
-78% -$3.81M ﹤0.01% 1198
2019
Q2 		$5.73M Sell
1,825,381
-748,902
-29% -$2.43M 0.01% 613
2019
Q1 		$9.58M Buy
2,574,283
+2,457,178
+2,098% +$8.3M 0.02% 572
2018
Q4 		$340K Buy
+117,105
New +$322K ﹤0.01% 1173
2017
Q2 		– Sell
-131,200
Closed -$298K – 1483
2017
Q1 		$298K Buy
+131,200
New +$290K ﹤0.01% 1151
2016
Q4 		– Sell
-365,050
Closed -$1.22M – 2955
2016
Q3 		$1.22M Sell
365,050
-50,808
-12% -$161K ﹤0.01% 1028
2016
Q2 		$1.31M Sell
415,858
-165,111
-28% -$551K ﹤0.01% 947
2016
Q1 		$1.94M Buy
580,969
+62,969
+12% +$196K 0.01% 819
2015
Q4 		$1.83M Buy
518,000
+448,200
+642% +$1.88M 0.01% 823
2015
Q3 		$351K Buy
+69,800
New +$400K ﹤0.01% 1170
2014
Q2 		– Sell
-943,334
Closed -$7.84M – 1368
2014
Q1 		$7.84M Sell
943,334
-892,103
-49% -$7.65M 0.05% 347
2013
Q4 		$15.5M Buy
1,835,437
+526,060
+40% +$4.43M 0.08% 221
2013
Q3 		$10.4M Sell
1,309,377
-117,947
-8% -$948K 0.07% 257
2013
Q2 		$11M Buy
+1,427,324
New +$11.1M 0.08% 208

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Arrowstreet Capital's PDLI Position: Q4 2020 in Review

Arrowstreet Capital sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 1,293,289 shares — an estimated $4.07M sold.

Arrowstreet Capital first reported a position in PDLI in Q2 2013 and held it in 18 quarters. The position peaked at $15.5M in Q4 2013. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Arrowstreet Capital reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Arrowstreet Capital sold 1,293,289 PDL BioPharma, Inc. shares in Q4 2020, an estimated $4.07M.
  • Arrowstreet Capital first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 18 quarters.
  • Arrowstreet Capital's PDL BioPharma, Inc. position peaked at $15.5M in Q4 2013.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Arrowstreet Capital's 13F filing for Q4 2020, filed 12 Feb 2021.